InfiMed debuts cardiac software
InfiMed debuts cardiac softwareMedical image processing firm InfiMed has introduced Cardiac View CV 1000, a cardiac cath lab imaging software package. The CV 1000 is a diagnostic-quality imaging tool designed for viewing cardiac cath lab patient
InfiMed debuts cardiac software
Medical image processing firm InfiMed has introduced Cardiac View CV 1000, a cardiac cath lab imaging software package. The CV 1000 is a diagnostic-quality imaging tool designed for viewing cardiac cath lab patient studies, according to the Liverpool, NY-based company. Workstation features include real-time review and edge enhancement, 1000-line display resolution, zoom, and image export to a hospitals intranet or the Web. InfiMed claims that the performance parameters of the DICOM-based CV 1000 were previously available only on hardware-based image workstations at 10 to 20 times the cost. InfiMed will also make CV 1000 available over the Internet. The company is offering free 14-day trials of the software via a downloadable Internet file or as a compact disk. As part of its future plans, the firm will also introduce a family of related products for cardiovascular applications.
- Search again
- Homepage
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
